187 related articles for article (PubMed ID: 22722882)
21. Random Number Generation in HIV Disease: Associations with Neuropsychological Functions and Activities of Daily Living.
Sheppard DP; Woods SP; Doyle KL; Verduzco M;
Arch Clin Neuropsychol; 2017 Feb; 32(1):53-62. PubMed ID: 28122765
[TBL] [Abstract][Full Text] [Related]
22. Functional disability in medication management and driving among individuals with HIV: a 1-year follow-up study.
Thames AD; Arentoft A; Rivera-Mindt M; Hinkin CH
J Clin Exp Neuropsychol; 2013; 35(1):49-58. PubMed ID: 23237014
[TBL] [Abstract][Full Text] [Related]
23. The impact of HIV-associated neuropsychological impairment on everyday functioning.
Heaton RK; Marcotte TD; Mindt MR; Sadek J; Moore DJ; Bentley H; McCutchan JA; Reicks C; Grant I;
J Int Neuropsychol Soc; 2004 May; 10(3):317-31. PubMed ID: 15147590
[TBL] [Abstract][Full Text] [Related]
24. The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: a systematic review.
Lovejoy TI; Suhr JA
J Behav Med; 2009 Oct; 32(5):389-405. PubMed ID: 19291386
[TBL] [Abstract][Full Text] [Related]
25. Resilience attenuates the association between neurocognitive functioning and everyday functioning in individuals aging with HIV in the Deep South.
Fazeli PL; Moore RC; Vance DE
Int J Geriatr Psychiatry; 2019 Jan; 34(1):72-78. PubMed ID: 30230608
[TBL] [Abstract][Full Text] [Related]
26. Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected persons.
Andrade AS; Deutsch R; A Celano S; Duarte NA; Marcotte TD; Umlauf A; Atkinson JH; McCutchan JA; Franklin D; Alexander TJ; McArthur JC; Marra C; Grant I; Collier AC
J Acquir Immune Defic Syndr; 2013 Mar; 62(3):282-92. PubMed ID: 23202813
[TBL] [Abstract][Full Text] [Related]
27. HIV medication adherence and HIV symptom severity: the roles of sleep quality and memory.
Babson KA; Heinz AJ; Bonn-Miller MO
AIDS Patient Care STDS; 2013 Oct; 27(10):544-52. PubMed ID: 24032625
[TBL] [Abstract][Full Text] [Related]
28. Psycho-behavioral factors associated with neurocognitive performance among people living with HIV on antiretroviral therapy in Accra, Ghana.
Asiedu N; Kretchy I; Asampong E
Afr Health Sci; 2020 Jun; 20(2):487-596. PubMed ID: 33163015
[TBL] [Abstract][Full Text] [Related]
29. Interactive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease.
Thaler NS; Sayegh P; Kim MS; Castellon SA; Hinkin CH
Arch Clin Neuropsychol; 2015 Mar; 30(2):114-21. PubMed ID: 25589442
[TBL] [Abstract][Full Text] [Related]
30. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
[TBL] [Abstract][Full Text] [Related]
31. Lower cognitive reserve among individuals with syndromic HIV-associated neurocognitive disorders (HAND).
Morgan EE; Woods SP; Smith C; Weber E; Scott JC; Grant I;
AIDS Behav; 2012 Nov; 16(8):2279-85. PubMed ID: 22677976
[TBL] [Abstract][Full Text] [Related]
32. Medication management abilities are reduced in older persons living with HIV compared with healthy older HIV- controls.
Cooley SA; Paul RH; Ances BM
J Neurovirol; 2020 Apr; 26(2):264-269. PubMed ID: 31989445
[TBL] [Abstract][Full Text] [Related]
33. Predicting medication adherence and employment status following kidney transplant: The relative utility of traditional and everyday cognitive approaches.
Gelb SR; Shapiro RJ; Thornton WJ
Neuropsychology; 2010 Jul; 24(4):514-26. PubMed ID: 20604625
[TBL] [Abstract][Full Text] [Related]
34. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.
Lawler K; Mosepele M; Ratcliffe S; Seloilwe E; Steele K; Nthobatsang R; Steenhoff A
J Int AIDS Soc; 2010 Apr; 13():15. PubMed ID: 20406460
[TBL] [Abstract][Full Text] [Related]
35. Association of Brain Structure Changes and Cognitive Function With Combination Antiretroviral Therapy in HIV-Positive Individuals.
Sanford R; Fellows LK; Ances BM; Collins DL
JAMA Neurol; 2018 Jan; 75(1):72-79. PubMed ID: 29131878
[TBL] [Abstract][Full Text] [Related]
36. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse.
Hinkin CH; Hardy DJ; Mason KI; Castellon SA; Durvasula RS; Lam MN; Stefaniak M
AIDS; 2004 Jan; 18 Suppl 1(Suppl 1):S19-25. PubMed ID: 15075494
[TBL] [Abstract][Full Text] [Related]
37. Depressive symptoms and neurocognitive performance among HIV-infected women.
Fialho RM; Pereira M; Mendonça N; Ouakinin S
Women Health; 2013; 53(2):117-34. PubMed ID: 23517511
[TBL] [Abstract][Full Text] [Related]
38. Stigma, disclosure, coping, and medication adherence among people living with HIV/AIDS in Northern Tanzania.
Lyimo RA; Stutterheim SE; Hospers HJ; de Glee T; van der Ven A; de Bruin M
AIDS Patient Care STDS; 2014 Feb; 28(2):98-105. PubMed ID: 24517541
[TBL] [Abstract][Full Text] [Related]
39. Menstrual cycle phase and single tablet antiretroviral medication adherence in women with HIV.
Hessol NA; Holman S; Minkoff H; Cohen MH; Golub ET; Kassaye S; Karim R; Sosanya O; Shaheen C; Merhi Z
AIDS Care; 2016; 28(1):11-21. PubMed ID: 26274806
[TBL] [Abstract][Full Text] [Related]
40. Memory-based strategies for antiretroviral medication management: an evaluation of clinical predictors, adherence behavior awareness, and effectiveness.
Blackstone K; Woods SP; Weber E; Grant I; Moore DJ;
AIDS Behav; 2013 Jan; 17(1):74-85. PubMed ID: 22968399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
